EUR 0.36
(0.42%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.32 EUR | -33.33% |
2022 | -0.24 EUR | -26.32% |
2021 | -0.19 EUR | 40.63% |
2020 | -0.32 EUR | 0.0% |
2019 | - EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.05 EUR | 0.0% |
2024 Q1 | -0.05 EUR | 46.7% |
2023 Q4 | -0.09 EUR | 0.0% |
2023 FY | - EUR | -33.33% |
2023 Q3 | -0.09 EUR | -40.0% |
2023 Q2 | -0.07 EUR | 0.0% |
2023 Q1 | -0.07 EUR | -21.6% |
2022 FY | - EUR | -26.32% |
2022 Q4 | -0.06 EUR | 0.0% |
2021 FY | - EUR | 40.63% |
2020 FY | - EUR | 0.0% |
2019 FY | - EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Nicox S.A. | -0.42 EUR | 23.81% |
European Medical Solutions | -0.00 EUR | -63900.0% |
PHAXIAM Therapeutics S.A. | -5.00 EUR | 93.6% |